Heterogeneous prognosis and adjuvant chemotherapy in pathological stage I non-small cell lung cancer patients

BACKGROUND: Even after curative resection, the prognosis of pathological stage I non-small cell lung cancer (NSCLC) can be heterogeneous, and the use of adjuvant chemotherapy in these patients is controversial. We aimed to identify the prognostic factors and role of adjuvant chemotherapy in patholog...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chia-Hsin, Peng, Yi-Jen, Wang, Hong-Hau, Chen, Ying-Chieh, Tsai, Chen-Liang, Chian, Chih-Feng, Huang, Tsai-Wang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567008/
https://www.ncbi.nlm.nih.gov/pubmed/26445611
http://dx.doi.org/10.1111/1759-7714.12233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567008/
https://www.ncbi.nlm.nih.gov/pubmed/26445611
http://dx.doi.org/10.1111/1759-7714.12233

Ejemplares similares